Cognitive Impairment in Patients with Chronic Kidney Disease: A Literature Review
Article Sidebar
Main Article Content
Abstract
Cognitive impairment is increasingly recognized in patients with chronic kidney disease (CKD), including those on kidney replacement therapy. Cognitive impairment is associated with a higher risk of hospitalization, dialysis withdrawal, and death. Understanding and early detection of this condition should attenuate these complications. CKD patients have more risk factors for developing cognitive impairment including traditional risk factors, CKD-related risk factors, and dialysis-related risk factors. These will affect through vascular dysfunction, impaired cerebral adaptation, chronic inflammation, and uremic toxins accumulation. Currently, effective therapy for cognitive impairment in CKD patients is somewhat limited. Therefore, understanding the mechanisms and avoiding the risk factors are the principal management to decrease the upcoming cognitive impairment.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This article is published under CC BY-NC-ND 4.0 license, which allows for non-commercial reuse of the published paper as long as the published paper is fully attributed. Anyone can share (copy and redistribute) the material in any medium or format without having to ask permission from the author or the Nephrology Society of Thailand.
References
Xie Z, Tong S, Chu X, Feng T, Geng M. Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis. Kidney Dis (Basel). 2022;8(4):275-85.
สมาคมโรคไตแห่งประเทศไทย. รายงานข้อมูลผู้ป่วยโรคไตเรื้อรัง พ.ศ.2565 [Internet]. Available from: https://www.nephrothai.org/wpcontent/uploads/2024/10/New-Annual-report-2021-2022.pdf
Lin YT, Wu PH, Liang SS, Mubanga M, Yang YH, Hsu YL et al. Protein-bound uremic toxins are associated with cognitive function among patients undergoing maintenance hemodialysis. Sci Rep. 2019;9(1):20388
สถาบันประสาทวิทยา กรมการแพทย์ กระทรวงสาธารณสุข. การวินิจฉัยภาวะสมองเสื่อม, ในแนวทางเวชปฏิบัติภาวะสมองเสื่อม. กรุงเทพฯ: บริษัท ธนาเพรส จำกัด; 2564. หน้า 29-30.
Viggiano D, Wagner CA, Martino G, Nedergaard M, Zoccali C, Unwin R et al. Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol. 2020;16(8):452-69.
Drew DA, Weiner DE, Sarnak MJ. Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention. Am J Kidney Dis. 2019;74(6):782-90.
Brodski, J., Rossell, S. L., Castle, D. J. & Tan, E. J. A systematic review of cognitive impairments associated with kidney failure in adults before natural age-related changes J Int Neuropsychol Soc. 2019;25:101–14.
O’Lone, E. et al. Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2016;67:925–35.
Harhay, M. N. et al. Cognitive impairment in non– dialysisdependent CKD and the transition to dialysis: findings from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2018;72:499–508.
Chu, N. M. et al. Frailty and changes in cognitive function after kidney transplantation. J Am Soc Nephrol. 2019;30:336–45.
Gennip ACEV, Broers NJH, Meulen KJT, Canaud B, Christiaans MHL, Cornelis T et al. Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy. PLoS One. 2019;14(9):e0222547
Tamura MK, Pajewski NM, Bryan RN, Weiner DE, Diamond M, Van Buren P et al; SPRINT Study Research Group. Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults. Neurology. 2016;86(13):1208-16.
Singh NP, Sahni V, Wadhwa A, Garg S, Bajaj SK, Kohli R et al. Effect of improvement in anemia on electroneurophysiological markers (P300) of cognitive dysfunction in chronic kidney disease. Hemodial Int. 2006;10(3):267-73.
Pérez-García R, Varas J, Cives A, Martín-Malo A, Aljama P et al. Increased mortality in haemodialysis patients administered high doses of erythropoiesis-stimulating agents: a propensity score-matched analysis. Nephrol Dial Transplant. 2018;33(4):690-9.
Sprick JD, Nocera JR, Hajjar I, O’Neill WC, Bailey J, Park J. Cerebral blood flow regulation in end-stage kidney disease. Am J Physiol Renal Physiol. 2020;319(5):F782-91
Kelly DM, Rothwell PM. Disentangling the Relationship Between Chronic Kidney Disease and Cognitive Disorders. Front Neurol. 2022;13:830064.
Lourida I, Thompson-Coon J, Dickens CM, Soni M, Kuźma E, Kos K et al. Parathyroid hormone, cognitive function and dementia: a systematic review. PLoS One. 2015;10(5):e0127574.
Díaz-Hernández M, Gómez-Ramos A, Rubio A, Gómez-Villafuertes R, Naranjo JR, Miras-Portugal MT et al. Tissuenonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau. J Biol Chem. 2010;285(42):32539-48
Mazumder MK, Phukan BC, Bhattacharjee A, Borah A. Disturbed purine nucleotide metabolism in chronic kidney disease is a risk factor for cognitive impairment. Med Hypotheses. 2018;111:36-9.
McGrath ER, Himali JJ, Levy D, Conner SC, Pase MP, Abraham CR et al. Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study. PLoS One. 2019;14(3):e0213321.
Zhu L, Stein LR, Kim D, Ho K, Yu GQ, Zhan L et al. Klotho controls the brain-immune system interface in the choroid plexus. Proc Natl Acad Sci U S A. 2018;115 (48):E11388-96
Paroni G, Panza F, De Cosmo S, Greco A, Seripa D, Mazzoccoli G. Klotho at the Edge of Alzheimer’s Disease and Senile Depression. Mol Neurobiol. 2019;56(3):1908-20.
Nagai T, Yamada K, Kim HC, Kim YS, Noda Y, Imura A et al. Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J. 2003;17(1):50-2.
Laszczyk AM, Nettles D, Pollock TA, Fox S, Garcia ML, Wang J et al. FGF-23 Deficiency Impairs Hippocampal-Dependent Cognitive Function. eNeuro. 2019;6(2):ENEURO.0469-18.
Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol. 2001;12(7):1549-57.
Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003;107(1):87-92
Szerlip HM, Edwards ML, Williams BJ, Johnson LA, Vintimilla RM, O’Bryant SE. Association Between Cognitive Impairment and Chronic Kidney Disease in Mexican Americans. J Am Geriatr Soc. 2015;63(10):2023-8.
Kurella Tamura M, Tam K, Vittinghoff E, Raj D, Sozio SM, Rosas SE et al ; CRIC Study Investigators. Inflammatory Markers and Risk for Cognitive Decline in Chronic Kidney Disease: The CRIC Study. Kidney Int Rep. 2017;2(2):192-200
Cheng Z, Lin J, Qian Q. Role of Vitamin D in Cognitive Function in Chronic Kidney Disease. Nutrients. 2016;8(5):291
Zhang QY, Jiang CM, Sun C, Tang TF, Jin B, Cao DW et al. Hypovitaminosis D is associated with endothelial dysfunction in patients with non-dialysis chronic kidney disease. J Nephrol. 2015;28(4):471-6.
Ghoshal S, Parikh A. Dialysis-Associated Neurovascular Injury (DANI) in Acute Brain Injury: Practical Considerations for Intermittent Dialysis in the Neuro-ICU. Clin J Am Soc Nephrol. 2021;16(7):1110-2
Kelly DM, Ademi Z, Doehner W, Lip GYH, Mark P, Toyoda K et al. Chronic Kidney Disease and Cerebrovascular Disease: Consensus and Guidance From a KDIGO Controversies Conference. Stroke. 2021;52(7):e328-46
Galons JP, Trouard T, Gmitro AF, Lien YH. Hemodialysis increases apparent diffusion coefficient of brain water in nephrectomized rats measured by isotropic diffusion-weighted magnetic resonance imaging. J Clin Invest. 1996;98(3):750-5
Polinder-Bos HA, García DV, Kuipers J, Elting JWJ, Aries MJH, Krijnen WP et al. Hemodialysis Induces an Acute Decline in Cerebral Blood Flow in Elderly Patients. J Am Soc Nephrol. 2018;29(4):1317-25
MacEwen C, Sutherland S, Daly J, Pugh C, Tarassenko L. Relationship between Hypotension and Cerebral Ischemia during Hemodialysis. J Am Soc Nephrol. 2017;28(8):2511-20
Watanabe A. Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis. J Stroke Cerebrovasc Dis. 2007;16(1):30-3
Zoccali C, D’Arrigo G, Leonardis D, Pizzini P, Postorino M, Tripepi G et al. Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study. J Hypertens. 2019;37(7):1359-65
Tian X, Guo X, Xia X, Yu H, Li X, Jiang A. The comparison of cognitive function and risk of dementia in CKD patients under peritoneal dialysis and hemodialysis: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2019;98(6):e14390
Joshee P, Wood AG, Wood ER, Grunfeld EA. Meta-analysis of cognitive functioning in patients following kidney transplantation. Nephrol Dial Transplant. 2018;33(7):1268-77
Pépin M, Ferreira AC, Arici M, Bachman M, Barbieri M, Bumblyte IA et al; A CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target). Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment. Nephrol Dial Transplant. 2021;37(Suppl2):ii23-32
Drew DA, Tighiouart H, Rollins J, Duncan S, Babroudi S, Scott T et al. Evaluation of Screening Tests for Cognitive Impairment in Patients Receiving Maintenance Hemodialysis. J Am Soc Nephrol. 2020;31(4):855-64
Jiang C, Li S, Wang Y, Lai Y, Bai Y, Zhao M et al. Diastolic Blood Pressure and Intensive Blood Pressure Control on Cognitive Outcomes: Insights From the SPRINT MIND Trial. Hypertension. 2023;80(3):580-9
Barzilay JI, Gao P, O’Donnell M, Mann JF, Anderson C, Fagard R et al; ONTARGET and TRANSCEND Investigators. Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies. Arch Intern Med. 2011;171(2):142-50
Wallace HJ, Wallace IR, McCaffrey P. Cognitive decline reversed by cinacalcet. QJM. 2015;108(1):59-61
Liberale, L. et al. Post-ischaemic administration of the murine canakinumab-surrogate antibody improves outcome in experimental stroke. Eur Heart J. 2018;39:3511–7.
Sil, S., Ghosh, R., Sanyal, M., Guha, D. & Ghosh, T. A comparison of neurodegeneration linked with neuroinflammation in different brain areas of rats after intracerebroventricular colchicine injection. J Immunotoxicol. 2016;13:181–90.
Yiannopoulou KG, Anastasiou AI, Kyrozis A, Anastasiou IP. Donepezil Treatment for Alzheimer’s Disease in Chronic Dialysis Patients. Case Rep Nephrol Dial. 2019;9(3):126-36
Cassano T, Magini A, Giovagnoli S, Polchi A, Calcagnini S, Pace L et al. Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer’s disease. Exp Neurol. 2019;311:88-105
Kurella Tamura M, Unruh ML, Nissenson AR, Larive B, Eggers PW, Gassman J et al, Stokes JB; Frequent Hemodialysis Network (FHN) Trial Group. Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials. Am J Kidney Dis. 2013;61(2):228-37.
Davenport A. Practical guidance for dialyzing a hemodialysis patient following acute brain injury. Hemodial Int. 2008;12(3):307-12.